SAVARA INC SVRA
COM · Common Stock · CUSIP 805111101 · ISIN US8051111016
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersAustin, TX
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($40.0k this quarter). Holder counts are more reliable. Shares outstanding: 114.0m as of 2022-11-10, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $1.55. Options: 6 managers hold calls ($328.0k notional), 1 hold puts ($0).
Biggest calls
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | $199.0k128.5k shares |
| GROUP ONE TRADING LLC | — | $94.0k60.4k shares |
| CITADEL ADVISORS LLC | — | $33.0k21.0k shares |
| SIMPLEX TRADING, LLC | — | $2.0k1.3k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | — | $00 shares |
| HAP Trading, LLC | — | $014.6k shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | — | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Growth Equity Opportunities 17, LLC
13D · may seek influence
filed 2025-11-14
Stated purposeGEO acquired the GEO Shares for investment purposes. Depending on market conditions, its continuing evaluation of the business and prospects of the Issuer and other factors, GEO and the other Reporting Persons may dispose of or acquire additional shares of the Issuer. Except as set forth above, none of the Reporting Persons has any present plans which relate to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or … Full filing |
12.0% |
| Bain Capital Life Sciences Fund II, L.P. 13D · may seek influence filed 2025-03-27 | 10.0% |
| Venrock Healthcare Capital Partners III, L.P. 13G · passive investor +2.6 pts · filed 2026-02-17 | 9.9% |
| Farallon Capital Partners, L.P. 13G · passive investor -3.1 pts · filed 2026-02-05 | 6.9% |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 13G · institution filed 2026-08-14 | 6.8% |
| Flynn James E 13G · passive investor new · filed 2025-11-05 | 6.7% |
| TCG Crossover GP I, LLC 13G · passive investor filed 2026-02-17 | 6.1% |
| BlackRock, Inc. 13G · institution +0.6 pts · filed 2026-01-21 | 5.4% |
Fell to 5% or below in the last year: Nantahala Capital Management, LLC (3.6%, 2026-02-13), Frazier Life Sciences Public Fund, L.P. (4.1%, 2026-02-13)
Insider purchases and sales in Q3 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 4 | $514.4k | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 1 | $138.7k | 0 | — | — |
| Q3 2022 | 1 | $384.9k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2022-09-27 | RAMSAY DAVID A Director | Bought | $101.2k73.9k shares |
| 2022-09-26 | RAMSAY DAVID A Director | Bought | $42.9k31.1k shares |
| 2022-09-23 | RAMSAY DAVID A Director | Bought | $42.6k30.0k shares |
| 2022-09-20 | RAMSAY DAVID A Director | Bought | $870600 shares |
| 2022-09-19 | RAMSAY DAVID A Director | Bought | $2.0k1.4k shares |
| 2022-09-16 | RAMSAY DAVID A Director | Bought | $8.6k6.0k shares |
| 2022-09-08 | RAMSAY DAVID A Director | Bought | $40.6k29.0k shares |
| 2022-09-07 | RAMSAY DAVID A Director | Bought | $3.0k2.1k shares |
| 2022-09-06 | RAMSAY DAVID A Director | Bought | $1.2k870 shares |
| 2022-09-01 | RAMSAY DAVID A Director | Bought | $56.5k39.8k shares |
| 2022-08-31 | RAMSAY DAVID A Director | Bought | $56.1k39.5k shares |
| 2022-08-30 | RAMSAY DAVID A Director | Bought | $29.2k20.7k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2022
| Manager | Shares | Change |
|---|---|---|
| NEA Management Company, LLC 1.87% of their portfolio | 24.1m $37.4m | — |
| Bain Capital Life Sciences Investors, LLC 2.15% of their portfolio | 11.6m $18.0m | — |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.09% of their portfolio | 9.9m $15.4m | — |
| CAXTON CORP 25.54% of their portfolio | 6.9m $10.7m | — |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.03% of their portfolio | 6.9m $10.6m | — |
| AXA S.A. 0.02% of their portfolio | 6.9m $10.6m | — |
| VANGUARD GROUP INC 0.00% of their portfolio | 4.8m $7.4m | — |
| Venrock Adviser, LLC 1.09% of their portfolio | 4.6m $7.1m | — |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 0.01% of their portfolio | 1.2m $1.9m | — |
| BlackRock Inc. 0.00% of their portfolio | 1.0m $1.6m | — |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 1.0m $1.6m | — |
| Sio Capital Management, LLC 0.57% of their portfolio | 856.4k $1.3m | — |
| Informed Momentum Co LLC 0.22% of their portfolio | 641.5k $994.0k | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.02% of their portfolio | 386.8k $600.0k | — |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.01% of their portfolio | 380.8k $590.0k | — |
| STATE STREET CORP 0.00% of their portfolio | 271.6k $421.0k | — |
| MORGAN STANLEY 0.00% of their portfolio | 191.3k $298.0k | — |
| FRANKLIN RESOURCES INC 0.00% of their portfolio | 183.9k $285.0k | — |
| Connor, Clark & Lunn Investment Management Ltd. 0.00% of their portfolio | 171.9k $266.0k | — |
| NORTHERN TRUST CORP 0.00% of their portfolio | 170.8k $265.0k | — |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 160.4k $249.0k | — |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 121.9k $189.0k | — |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 113.5k $176.0k | — |
| PURA VIDA INVESTMENTS, LLC 0.02% of their portfolio | 95.0k $147.0k | — |
| Bank of New York Mellon Corp 0.00% of their portfolio | 86.2k $134.0k | — |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 81.4k $126.0k | — |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 70.0k $109.0k | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 67.3k $105.0k | — |
| Mariner, LLC 0.00% of their portfolio | 46.7k $72.0k | — |
| Marquette Asset Management, LLC 0.02% of their portfolio | 46.2k $72.0k | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 42.9k $67.0k | — |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 34.1k $53.0k | — |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 29.0k $45.0k | — |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC 0.00% of their portfolio | 25.8k $40.0k | — |
| TELEMUS CAPITAL, LLC 0.00% of their portfolio | 25.2k $39.0k | — |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 21.5k $33.0k | — |
| BROWN ADVISORY INC 0.00% of their portfolio | 20.9k $32.0k | — |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 18.1k $28.0k | — |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 17.9k $28.0k | — |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 17.0k $26.0k | — |
| Leonteq Securities AG 0.00% of their portfolio | 15.0k $23.2k | — |
| Gladstone Institutional Advisory LLC 0.00% of their portfolio | 14.0k $22.0k | — |
| TIAA, FSB 0.00% of their portfolio | 11.3k $18.0k | — |
| HIGHLAND CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 10.0k $15.0k | — |
| J.W. COLE ADVISORS, INC. 0.00% of their portfolio | 10.0k $16.0k | — |
| Crewe Advisors LLC 0.00% of their portfolio | 3.9k $6.0k | — |
| FMR LLC 0.00% of their portfolio | 1.7k $3.0k | — |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 585 $1.0k | — |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 507 $1.0k | — |
| UBS Group AG 0.00% of their portfolio | 395 $1.0k | — |
| EARNEST PARTNERS LLC 0.00% of their portfolio | 77 $0 | — |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 8 $0 | — |
| Corus Family Wealth Advisors 0.00% of their portfolio | 4 $0 | — |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 2 $0 | — |
| Halpern Financial, Inc. 0.00% of their portfolio | 2 $3 | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |